Literature DB >> 1528273

[3H]R75231--a new radioligand for the nitrobenzylthioinosine sensitive nucleoside transport proteins. Characterization of (+/-)-[3H]R75231 binding to calf lung membranes, stereospecificity of its two stereoisomers, and comparison with [3H]nitrobenzylthioinosine binding.

A P IJzerman1, M Kruidering, A van Weert, H van Belle, C Janssen.   

Abstract

The tritiated analogue of R75231 ((+-)-2-(aminocarbonyl)-N-(4-amino-2,6-dichlorophenyl)-4-[5,5-bis (4-fluorophenyl)pentyl]-1-piperazineacetamide) has been examined as a new radioligand for (nitrobenzylthioinosine sensitive) nucleoside transport proteins. [3H]R75231 was prepared in two steps from R69064 ((+-)-4-[5,5-bis[4-fluorophenyl)-4-pentenyl]-2-piperazinecarboxamide+ ++ dihydrochloride) with a specific activity of 0.23 TBq/mmol (6.3 Ci/mmol). [3H]R75231 bound in a pseudo-irreversible and saturable manner to a membrane preparation of calf lung tissue. The new radioligand displayed high affinity (KD = 0.32 +/- 0.06 nmol/l at 25 degrees C) and capacity (Bmax = 6.1 +/- 0.3 pmol/mg protein). Specific [3H]R75231 binding could be fully displaced by both structural analogues and reference inhibitors such as dipyridamole, NBI, dilazep and hexobendine, as well as by various nucleosides. The two stereoisomers of R75231, R88016 ((+)-R75231) and R88021 ((-)-R-75231), potently displaced specific [3H]R75231 and [3H]NBI binding, R88021 being 30-fold more active than R88016. Pseudo-Hill coefficients derived from the shape of all the [3H]R75231 displacement curves were approximately unity. In contrast, R75231 and most of its analogues displaced specific [3H]NBI binding with pseudo-Hill coefficients consistently larger than unity under identical experimental conditions. This latter finding is suggestive for the existence of two distinct binding sites for the two radioligands, which may or may not overlap to some extent.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1528273     DOI: 10.1007/bf00168949

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  13 in total

1.  Inhibition of nucleoside uptake in human erythrocytes by a new series of compounds related to lidoflazine and mioflazine.

Authors:  I M Pirovano; H Van Belle; A P Ijzerman
Journal:  Eur J Pharmacol       Date:  1990-12-15       Impact factor: 4.432

2.  Ca2+ antagonist receptor sites on human red blood cell membranes.

Authors:  J Striessnig; G Zernig; H Glossmann
Journal:  Eur J Pharmacol       Date:  1985-02-05       Impact factor: 4.432

3.  [3H]dipyridamole: a new ligand probe for brain adenosine uptake sites.

Authors:  P J Marangos; M Houston; P Montgomery
Journal:  Eur J Pharmacol       Date:  1985-11-19       Impact factor: 4.432

4.  Two affinity states of Ri adenosine receptors in brain membranes. Analysis of guanine nucleotide and temperature effects on radioligand binding.

Authors:  M J Lohse; V Lenschow; U Schwabe
Journal:  Mol Pharmacol       Date:  1984-07       Impact factor: 4.436

5.  The relationship between ionization and affinity of nucleoside transport inhibitors.

Authors:  A P IJzerman; A H Voorschuur
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-09       Impact factor: 3.000

6.  A refined method for the photoaffinity labelling of the nitrobenzylthioinosine-sensitive nucleoside transport protein: application to cell membranes of calf lung tissue.

Authors:  A P IJzerman; G J Menkveld; K H Thedinga
Journal:  Biochim Biophys Acta       Date:  1989-02-27

7.  Inhibition of nucleoside transport by a new series of compounds related to lidoflazine and mioflazine.

Authors:  A P Ijzerman; K H Thedinga; A F Custers; B Hoos; H Van Belle
Journal:  Eur J Pharmacol       Date:  1989-08-15       Impact factor: 4.432

8.  Human red-blood-cell Ca2+-antagonist binding sites. Evidence for an unusual receptor coupled to the nucleoside transporter.

Authors:  J Striessnig; G Zernig; H Glossmann
Journal:  Eur J Biochem       Date:  1985-07-01

9.  Interaction of [3H]dilazep at nucleoside transporter-associated binding sites on S49 mouse lymphoma cells.

Authors:  W P Gati; A R Paterson
Journal:  Mol Pharmacol       Date:  1989-07       Impact factor: 4.436

10.  Potencies of mioflazine and its derivatives as inhibitors of adenosine transport in isolated erythrocytes from different species.

Authors:  H P Baer; A Haq; A el-Soofi; V Serignese; A R Paterson
Journal:  J Pharm Pharmacol       Date:  1990-05       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.